References
Liu X, Tang J, Wang M, Ma Q, Wang Y. Visual detection and evaluation of latent and lytic gene expression during Epstein–Barr virus infection using one–step reverse transcription loop–mediated isothermal amplification. Int J Mol Sci 2013; 14: 23922–40.
Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991; 18: 1741–3.
Gaulard P, Swerdlow SH, Harris L, Jaffe ES, Sundstrom C. Other iatrogenic immunodeficiency–associated lymphoproliferative disorders. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Swerdlow SH, Campo E, Harris NL, et al. Lyon: IARC Press, 2008: 350–1.
Mariette X, Cazals–Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3–year prospective study in France. Blood 2002; 99: 3909–15.
Hoshida Y, Xu JX, Fujita S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 2007; 34: 322–31.
Kojima M, Itoh H, Hirabayashi K, et al. Methtrexate–associated lymphoproliferative disorders. a clinicopathological study of 13 Japanese cases. Pathol Res Pract 2006; 202: 679–85.
Ichikawa A, Arakawa F, Kiyasu J, et al. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein–Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 2013; 91: 20–8.
Terroso G, Aleixo J, Bernardes M, Mariz E, Fonseca E, Costa L. Nasal type extranodal NK/T cell lymphoma diagnosed in a patient with rheumatoid arthritis under methotrexate. Acta Reumatol Port 2014; 39: 77–81.
Kondo S, Tanimoto K, Yamada K, et al. Mature T/NK–cell lymphoproliferative disease and Epstein–Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate. Virchows Arch 2013; 462: 399–407.
Yamakawa N, Fujimoto M, Kawabata D, et al. A clinical, pathological, and genetic characterization of methotrexate–associated lymphoproliferative disorders. J Rheumatol 2014; 41: 293–9.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Matsuzaki, Y., Minakawa, S., Sagara, C. et al. Spontaneous remission of methotrexateassociated lymphoproliferative disorder with Epstein-Barr virus type II latency. Eur J Dermatol 28, 693–694 (2018). https://doi.org/10.1684/ejd.2018.3372
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2018.3372